In the seventeen month time period of this retrospective study, there were 11,719 HBsAg tests ordered for 9,930 patients (with some patients being tested two or more separate times during the time ...
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...
We constructed decision-analytic models to analyze three strategies (no screening, universal screening, and selective screening based on use of an HBV infection risk tool) for hypothetic cohorts of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Up to 19% of patients who received JNJ-3989 achieved ...
October 30, 2006 — The US Food and Drug Administration (FDA) has approved a third-generation, point-of-care qualitative immunoassay for HIV-1 antibodies (Reveal G3) that eliminates the need for ...
Please provide your email address to receive an email when new articles are posted on . HBV-infected children treated with combination PEG-INF a-2b/nucleos(t)ide analogues achieved higher HBsAg loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback